Department of Neurology, Jiangxi Provincial People's Hospital, Affiliated People's Hospital of Nanchang University, Nanchang, China.
Front Immunol. 2022 Apr 11;13:874978. doi: 10.3389/fimmu.2022.874978. eCollection 2022.
Amyotrophic lateral sclerosis (ALS) is a fatal neurodegenerative disease, and its candidate biomarkers have not yet been fully elucidated in previous studies. Therefore, with the present study, we aim to define and verify effective biomarkers of ALS by bioinformatics. Here, we employed differentially expressed gene (DEG) analysis, weighted gene co-expression network analysis (WGCNA), enrichment analysis, immune infiltration analysis, and protein-protein interaction (PPI) to identify biomarkers of ALS. To validate the biomarkers, we isolated the lumbar spinal cord from mice and characterized them using Western blotting and immunofluorescence. The results showed that Dhrs4 expression in the spinal cord was upregulated with the progression of SOD1 mice, and the upregulation of DHRS4 and its synergistic DHRS3 might be primarily associated with the activation of the complement cascade in the immune system (C1QA, C1QB, C1QC, C3, and ITGB2), which might be a novel mechanism that induces spinal neurodegeneration in ALS. We propose that DHRS4 and its synergistic DHRS3 are promising molecular markers for detecting ALS progression.
肌萎缩侧索硬化症(ALS)是一种致命的神经退行性疾病,其候选生物标志物在以前的研究中尚未完全阐明。因此,在本研究中,我们旨在通过生物信息学来定义和验证 ALS 的有效生物标志物。在这里,我们采用差异表达基因(DEG)分析、加权基因共表达网络分析(WGCNA)、富集分析、免疫浸润分析和蛋白质-蛋白质相互作用(PPI)来识别 ALS 的生物标志物。为了验证这些生物标志物,我们从小鼠中分离出腰椎脊髓,并通过 Western blot 和免疫荧光对其进行了表征。结果表明,SOD1 小鼠脊髓中 Dhrs4 的表达随疾病的进展而上调,DHRS4 的上调及其协同的 DHRS3 可能主要与免疫系统中补体级联的激活(C1QA、C1QB、C1QC、C3 和 ITGB2)有关,这可能是诱导 ALS 中脊髓神经退行性变的新机制。我们提出,DHRS4 及其协同的 DHRS3 是检测 ALS 进展的有前途的分子标志物。